Clinical relevance of TDM of SSRIs

Ther Drug Monit. 2006 Oct;28(5):716-7; author reply 717. doi: 10.1097/01.ftd.0000245378.87563.72.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cytochrome P-450 CYP2D6 / genetics*
  • Drug Interactions
  • Drug Monitoring / methods*
  • Humans
  • Patient Compliance
  • Pharmacogenetics
  • Selective Serotonin Reuptake Inhibitors / metabolism*

Substances

  • Serotonin Uptake Inhibitors
  • Cytochrome P-450 CYP2D6